整合细胞类型特异性基因表达与全基因组关联识别精神分裂症风险基因
该研究整合四种脑细胞类型特异性eQTL数据与精神分裂症全基因组关联数据,分别进行孟德尔随机化并荟萃分析,识别出多种细胞类型中表达水平与精神分裂症存在因果关联的基因,并优先筛选出MAU2和PPP1R13B等最可信因果基因,最后进行药物靶点分析评估治疗潜力。
要点
- 兴奋性神经元中识别出148个表达水平与精神分裂症因果关联的显著基因。
- 脑组织eQTL分析识别出206个表达水平与精神分裂症因果关联的基因。
- 整合多证据优先筛选出MAU2和PPP1R13B为最可信因果基因。
核心结论
- 细胞类型特异性基因表达与精神分裂症存在因果关联,为机制研究和治疗干预提供候选靶点。
研究设计与样本
- 整合四种细胞类型特异性eQTL数据集与精神分裂症全基因组关联数据分别进行孟德尔随机化,并进行荟萃分析。
- 另使用脑组织eQTL数据进行孟德尔随机化,并整合多证据优先筛选因果基因及进行药物靶点分析。
主要发现
- 兴奋性神经元中识别出148个显著基因,抑制性神经元71个,星形胶质细胞63个,小胶质细胞48个,少突胶质细胞70个,少突胶质前体细胞39个,内皮细胞20个,周细胞7个。
- 使用脑组织eQTL数据识别出206个表达水平与精神分裂症因果关联的基因。
- 整合多证据优先筛选出最可信因果基因包括MAU2和PPP1R13B。
临床怎么用
- 研究结果提示MAU2和PPP1R13B等基因可作为精神分裂症机制研究与治疗干预的候选靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Integrative studies such as transcriptome-wide association studies (TWAS) and Mendelian randomization (MR) have identified multiple risk genes whose expression level is associated with schizophrenia (SCZ). However, the vast majority of integrative studies are based on quantitative trait loci (QTL) data from bulk brain tissues. Given that gene expression and genetic regulatory effects are highly dependent on cell types, it is important to conduct integrative studies using expression data from specific brain cell types. Here, we investigate the causality between cell-type-specific gene expression and SCZ. We first conducted MR by integrating four cell-type-specific expression quantitative trait loci (eQTL) datasets and genome-wide associations of SCZ separately. We then performed a meta-analysis to explore the causal relationships between gene expression in different human brain cell types and SCZ. We identified multiple genes whose cell-type-specific expression levels are causally associated with SCZ, including 148 significant genes in excitatory neurons, 71 in inhibitory neurons, 63 in astrocytes, 48 in microglia, 70 in oligodendrocytes, 39 in oligodendrocyte precursor cells, 20 in endothelial cells, and 7 in pericytes. We also performed MR using eQTL data from brain tissues and identified 206 genes whose expression levels are causally associated with SCZ. By integrating multiple lines of evidence, we prioritized the most plausible causal genes, including the MAU2 and PPP1R13B. Finally, we performed a drug target analysis to evaluate the therapeutic potential of these genes. Our study reveals the causal relationships between cell-type-specific gene expression and SCZ, providing promising targets for mechanistic investigation and therapeutic interventions.
引用
- Lou W, Dang X, Luo XJ, et al. Integrating cell-type-specific gene expression and genome-wide associations identifies risk genes for schizophrenia. Mol Psychiatry. 2026. PMID: 42106519. doi:10.1038/s41380-026-03652-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。